Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Translational Lung Cancer Research|April 23, 2021
Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer-an option for overcoming EGFR-TKI resistanceRuoshuang Han, Yijun Jia, Xuefei Li, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancerSha Zhao, Guanghui Gao, Wei Li, et al.
Journal for Immunotherapy of Cancer|December 21, 2022
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancerMeng Qiao, Fei Zhou, Xinyu Liu, et al.
Cancer Medicine|November 24, 2017
Prognostic value of PD-L1 expression in combination with CD8<sup>+</sup> TILs density in patients with surgically resected non-small cell lung cancerHui Yang, Jinpeng Shi, Dongmei Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancerYijun Jia, Xuefei Li, Chao Zhao, et al.
The Journal of Pathology|June 8, 2018
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphomaZebing Liu, Ying Cai, Yu Yang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 11, 2019
Clinical Effect of Intravenous Vitamin C on Viral Myocarditis in Children: A Systematic Review and Meta-AnalysisShuangdi Chen, Wenli Zhao, Binjie Zhang, et al.
International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.
Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Uncommon <i>EGFR</i> mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapyJinpeng Shi, Hui Yang, Tao Jiang, et al.
Pageof 5